King's College Hospital, NHS Foundation Trust, London, UK.
Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
BMJ Open. 2022 Nov 16;12(11):e066650. doi: 10.1136/bmjopen-2022-066650.
To inform UK service development to support medical abortion at home, appropriate for person and context.
Realist review SETTING/PARTICIPANTS: Peer-reviewed literature from 1 January 2000 to 9 December 2021, describing interventions or models of home abortion care. Participants included people seeking or having had an abortion.
Interventions and new models of abortion care relevant to the UK.
Causal explanations, in the form of context-mechanism-outcome configurations, to test and develop our realist programme theory.
We identified 12 401 abstracts, selecting 944 for full text assessment. Our final review included 50 papers. Medical abortion at home is safe, effective and acceptable to most, but clinical pathways and user experience are variable and a minority would not choose this method again. Having a choice of abortion location remains essential, as some people are unable to have a medical abortion at home. Choice of place of abortion (home or clinical setting) was influenced by service factors (appointment number, timing and wait-times), personal responsibilities (caring/work commitments), geography (travel time/distance), relationships (need for secrecy) and desire for awareness/involvement in the process. We found experiences could be improved by offering: an option for self-referral through a telemedicine consultation, realistic information on a range of experiences, opportunities to personalise the process, improved pain relief, and choice of when and how to discuss contraception.
Acknowledging the work done by patients when moving medical abortion care from clinic to home is important. Patients may benefit from support to: prepare a space, manage privacy and work/caring obligations, decide when/how to take medications, understand what is normal, assess experience and decide when and how to ask for help. The transition of this complex intervention when delivered outside healthcare environments could be supported by strategies that reduce surprise or anxiety, enabling preparation and a sense of control.
为支持在英国家庭中进行药物流产服务的发展提供信息,使其符合个人和环境的需求。
对 2000 年 1 月 1 日至 2021 年 12 月 9 日期间发表的同行评审文献进行的现实主义综述,描述了与英国相关的家庭堕胎护理干预措施或模式。参与者包括寻求或已经进行过堕胎的人。
与英国相关的堕胎护理的干预措施和新模式。
以语境-机制-结局配置的形式提出因果解释,以检验和发展我们的现实主义方案理论。
我们共确定了 12401 篇摘要,其中 944 篇进行了全文评估。我们最终的综述包括 50 篇论文。在家中进行药物流产是安全、有效且大多数人都能接受的,但临床途径和用户体验存在差异,少数人不会再次选择这种方法。拥有选择堕胎地点的权利仍然至关重要,因为有些人无法在家中进行药物流产。选择堕胎地点(家庭或临床环境)受到服务因素(预约数量、时间和等待时间)、个人责任(照顾/工作承诺)、地理位置(旅行时间/距离)、人际关系(需要保密)和对过程的认识/参与度的影响。我们发现,通过远程医疗咨询提供自我转诊的选择、提供关于各种体验的现实信息、个性化流程的机会、改善疼痛缓解以及选择何时以及如何讨论避孕措施,可以改善体验。
承认患者在将药物流产护理从诊所转移到家庭时所做的工作很重要。患者可能会受益于以下支持:准备空间、管理隐私和工作/照顾义务、决定何时/如何服用药物、了解正常情况、评估体验以及决定何时以及如何寻求帮助。当在医疗环境之外提供这种复杂的干预措施时,可以通过减少意外或焦虑的策略来支持其过渡,从而使患者能够做好准备并获得控制感。